nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—SLC16A1—Methotrexate—urinary bladder cancer	0.11	0.917	CbGbCtD
Niacin—HCAR2—prostate gland—urinary bladder cancer	0.0218	0.102	CbGeAlD
Niacin—QPRT—renal system—urinary bladder cancer	0.0177	0.0833	CbGeAlD
Niacin—QPRT—female reproductive system—urinary bladder cancer	0.0142	0.0667	CbGeAlD
Niacin—NNMT—prostate gland—urinary bladder cancer	0.0123	0.0576	CbGeAlD
Niacin—NNMT—seminal vesicle—urinary bladder cancer	0.0104	0.0487	CbGeAlD
Niacin—CYP2D6—Doxorubicin—urinary bladder cancer	0.00993	0.0831	CbGbCtD
Niacin—NNMT—smooth muscle tissue—urinary bladder cancer	0.00868	0.0408	CbGeAlD
Niacin—SLC16A3—prostate gland—urinary bladder cancer	0.00837	0.0393	CbGeAlD
Niacin—NNMT—renal system—urinary bladder cancer	0.00835	0.0393	CbGeAlD
Niacin—NNMT—urethra—urinary bladder cancer	0.00821	0.0386	CbGeAlD
Niacin—SLC16A3—Azacitidine—Gemcitabine—urinary bladder cancer	0.00803	1	CbGdCrCtD
Niacin—HCAR2—lymph node—urinary bladder cancer	0.00696	0.0327	CbGeAlD
Niacin—NNMT—female reproductive system—urinary bladder cancer	0.00669	0.0314	CbGeAlD
Niacin—SLC16A3—epithelium—urinary bladder cancer	0.00615	0.0289	CbGeAlD
Niacin—NNMT—vagina—urinary bladder cancer	0.00605	0.0284	CbGeAlD
Niacin—SLC16A3—smooth muscle tissue—urinary bladder cancer	0.00593	0.0279	CbGeAlD
Niacin—SLC16A3—renal system—urinary bladder cancer	0.00571	0.0268	CbGeAlD
Niacin—SLC16A3—urethra—urinary bladder cancer	0.00561	0.0263	CbGeAlD
Niacin—CYP2D6—urine—urinary bladder cancer	0.00522	0.0245	CbGeAlD
Niacin—SLC16A1—prostate gland—urinary bladder cancer	0.00509	0.0239	CbGeAlD
Niacin—SLC16A3—female reproductive system—urinary bladder cancer	0.00457	0.0215	CbGeAlD
Niacin—SLCO2B1—prostate gland—urinary bladder cancer	0.00438	0.0206	CbGeAlD
Niacin—NNMT—lymph node—urinary bladder cancer	0.00391	0.0184	CbGeAlD
Niacin—SLC16A1—epithelium—urinary bladder cancer	0.00374	0.0176	CbGeAlD
Niacin—SLC16A1—renal system—urinary bladder cancer	0.00347	0.0163	CbGeAlD
Niacin—SLCO2B1—renal system—urinary bladder cancer	0.00298	0.014	CbGeAlD
Niacin—SLC22A5—prostate gland—urinary bladder cancer	0.00291	0.0137	CbGeAlD
Niacin—SLC16A1—female reproductive system—urinary bladder cancer	0.00278	0.013	CbGeAlD
Niacin—SLC16A3—lymph node—urinary bladder cancer	0.00267	0.0126	CbGeAlD
Niacin—SLC22A5—seminal vesicle—urinary bladder cancer	0.00246	0.0116	CbGeAlD
Niacin—SLCO2B1—female reproductive system—urinary bladder cancer	0.00239	0.0112	CbGeAlD
Niacin—SLC22A5—renal system—urinary bladder cancer	0.00198	0.00931	CbGeAlD
Niacin—SLC22A5—urethra—urinary bladder cancer	0.00195	0.00914	CbGeAlD
Niacin—SLC16A1—lymph node—urinary bladder cancer	0.00162	0.00763	CbGeAlD
Niacin—SLC22A5—female reproductive system—urinary bladder cancer	0.00159	0.00745	CbGeAlD
Niacin—SLC22A5—vagina—urinary bladder cancer	0.00143	0.00674	CbGeAlD
Niacin—SLCO2B1—lymph node—urinary bladder cancer	0.0014	0.00657	CbGeAlD
Niacin—CYP2D6—renal system—urinary bladder cancer	0.00128	0.00601	CbGeAlD
Niacin—CYP2D6—female reproductive system—urinary bladder cancer	0.00102	0.00481	CbGeAlD
Niacin—SLC22A5—lymph node—urinary bladder cancer	0.000928	0.00436	CbGeAlD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—KRAS—urinary bladder cancer	0.000424	0.00151	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—GSTZ1—urinary bladder cancer	0.000423	0.00151	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—GLI1—urinary bladder cancer	0.000421	0.0015	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000417	0.00149	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—UGT2B7—urinary bladder cancer	0.000417	0.00149	CbGpPWpGaD
Niacin—NNMT—Metabolism—HPGDS—urinary bladder cancer	0.000409	0.00146	CbGpPWpGaD
Niacin—NNMT—Metabolism—ENO2—urinary bladder cancer	0.000409	0.00146	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—GSTO2—urinary bladder cancer	0.000401	0.00143	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—NAT1—urinary bladder cancer	0.000401	0.00143	CbGpPWpGaD
Niacin—NNMT—Metabolism—GSTT1—urinary bladder cancer	0.000397	0.00141	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000395	0.00141	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000387	0.00138	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.00038	0.00136	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CYP4B1—urinary bladder cancer	0.000375	0.00134	CbGpPWpGaD
Niacin—SLC5A8—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000371	0.00132	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—UGT2B7—urinary bladder cancer	0.000367	0.00131	CbGpPWpGaD
Niacin—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.000362	0.000955	CcSEcCtD
Niacin—CYP2D6—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000362	0.00129	CbGpPWpGaD
Niacin—Dry skin—Doxorubicin—urinary bladder cancer	0.000361	0.000953	CcSEcCtD
Niacin—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000361	0.000952	CcSEcCtD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—HRAS—urinary bladder cancer	0.00036	0.00128	CbGpPWpGaD
Niacin—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.00036	0.000949	CcSEcCtD
Niacin—Angina pectoris—Epirubicin—urinary bladder cancer	0.000359	0.000946	CcSEcCtD
Niacin—HCAR2—GPCR ligand binding—CXCL8—urinary bladder cancer	0.000358	0.00128	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—IFNA2—urinary bladder cancer	0.000358	0.00128	CbGpPWpGaD
Niacin—Anorexia—Etoposide—urinary bladder cancer	0.000356	0.000939	CcSEcCtD
Niacin—Diarrhoea—Thiotepa—urinary bladder cancer	0.000356	0.000938	CcSEcCtD
Niacin—Decreased appetite—Cisplatin—urinary bladder cancer	0.000355	0.000934	CcSEcCtD
Niacin—SLC16A3—Metabolism—SLC19A1—urinary bladder cancer	0.000355	0.00126	CbGpPWpGaD
Niacin—QPRT—Metabolism—NQO1—urinary bladder cancer	0.000355	0.00126	CbGpPWpGaD
Niacin—Bronchitis—Epirubicin—urinary bladder cancer	0.000354	0.000934	CcSEcCtD
Niacin—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000352	0.000928	CcSEcCtD
Niacin—Hypotension—Etoposide—urinary bladder cancer	0.000349	0.00092	CcSEcCtD
Niacin—Pain—Cisplatin—urinary bladder cancer	0.000349	0.000919	CcSEcCtD
Niacin—SLCO2B1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000349	0.00124	CbGpPWpGaD
Niacin—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000348	0.000917	CcSEcCtD
Niacin—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000346	0.000912	CcSEcCtD
Niacin—SLC16A3—Metabolism—PRSS3—urinary bladder cancer	0.000345	0.00123	CbGpPWpGaD
Niacin—Dizziness—Thiotepa—urinary bladder cancer	0.000344	0.000907	CcSEcCtD
Niacin—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000343	0.000904	CcSEcCtD
Niacin—Stomatitis—Methotrexate—urinary bladder cancer	0.000342	0.000902	CcSEcCtD
Niacin—Urticaria—Fluorouracil—urinary bladder cancer	0.000342	0.000901	CcSEcCtD
Niacin—Dysphagia—Doxorubicin—urinary bladder cancer	0.000341	0.000898	CcSEcCtD
Niacin—Influenza—Doxorubicin—urinary bladder cancer	0.000341	0.000898	CcSEcCtD
Niacin—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00034	0.000896	CcSEcCtD
Niacin—HCAR3—GPCR ligand binding—CXCL8—urinary bladder cancer	0.00034	0.00121	CbGpPWpGaD
Niacin—Sweating—Methotrexate—urinary bladder cancer	0.000336	0.000887	CcSEcCtD
Niacin—Paraesthesia—Etoposide—urinary bladder cancer	0.000335	0.000884	CcSEcCtD
Niacin—Dyspnoea—Etoposide—urinary bladder cancer	0.000333	0.000878	CcSEcCtD
Niacin—Somnolence—Etoposide—urinary bladder cancer	0.000332	0.000876	CcSEcCtD
Niacin—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000332	0.000875	CcSEcCtD
Niacin—Vomiting—Thiotepa—urinary bladder cancer	0.000331	0.000872	CcSEcCtD
Niacin—CYP2D6—Biological oxidations—CYP4B1—urinary bladder cancer	0.00033	0.00118	CbGpPWpGaD
Niacin—NNMT—Metabolism—NQO1—urinary bladder cancer	0.00033	0.00118	CbGpPWpGaD
Niacin—Rash—Thiotepa—urinary bladder cancer	0.000328	0.000864	CcSEcCtD
Niacin—Bronchitis—Doxorubicin—urinary bladder cancer	0.000328	0.000864	CcSEcCtD
Niacin—Dermatitis—Thiotepa—urinary bladder cancer	0.000328	0.000864	CcSEcCtD
Niacin—SLC22A5—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000327	0.00117	CbGpPWpGaD
Niacin—Headache—Thiotepa—urinary bladder cancer	0.000326	0.000859	CcSEcCtD
Niacin—CYP2D6—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000326	0.00116	CbGpPWpGaD
Niacin—Decreased appetite—Etoposide—urinary bladder cancer	0.000325	0.000856	CcSEcCtD
Niacin—QPRT—Disease—NCOR1—urinary bladder cancer	0.000324	0.00116	CbGpPWpGaD
Niacin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000323	0.00085	CcSEcCtD
Niacin—Body temperature increased—Cisplatin—urinary bladder cancer	0.000322	0.00085	CcSEcCtD
Niacin—Jaundice—Epirubicin—urinary bladder cancer	0.00032	0.000844	CcSEcCtD
Niacin—Stomatitis—Epirubicin—urinary bladder cancer	0.00032	0.000844	CcSEcCtD
Niacin—Pain—Etoposide—urinary bladder cancer	0.000319	0.000842	CcSEcCtD
Niacin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000317	0.000835	CcSEcCtD
Niacin—Haemoglobin—Methotrexate—urinary bladder cancer	0.000317	0.000835	CcSEcCtD
Niacin—Hepatitis—Methotrexate—urinary bladder cancer	0.000315	0.00083	CcSEcCtD
Niacin—Haemorrhage—Methotrexate—urinary bladder cancer	0.000315	0.00083	CcSEcCtD
Niacin—Sweating—Epirubicin—urinary bladder cancer	0.000315	0.00083	CcSEcCtD
Niacin—Asthenia—Gemcitabine—urinary bladder cancer	0.000314	0.000827	CcSEcCtD
Niacin—SLC16A1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.00031	0.0011	CbGpPWpGaD
Niacin—Pruritus—Gemcitabine—urinary bladder cancer	0.00031	0.000816	CcSEcCtD
Niacin—Nausea—Thiotepa—urinary bladder cancer	0.000309	0.000814	CcSEcCtD
Niacin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000306	0.000805	CcSEcCtD
Niacin—QPRT—Disease—ERCC2—urinary bladder cancer	0.000305	0.00109	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—RBX1—urinary bladder cancer	0.000305	0.00109	CbGpPWpGaD
Niacin—Pruritus—Fluorouracil—urinary bladder cancer	0.000304	0.000802	CcSEcCtD
Niacin—Visual impairment—Methotrexate—urinary bladder cancer	0.000304	0.0008	CcSEcCtD
Niacin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.0003	0.000792	CcSEcCtD
Niacin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000299	0.000789	CcSEcCtD
Niacin—Urticaria—Etoposide—urinary bladder cancer	0.000297	0.000782	CcSEcCtD
Niacin—Haemoglobin—Epirubicin—urinary bladder cancer	0.000296	0.000781	CcSEcCtD
Niacin—Jaundice—Doxorubicin—urinary bladder cancer	0.000296	0.000781	CcSEcCtD
Niacin—Stomatitis—Doxorubicin—urinary bladder cancer	0.000296	0.000781	CcSEcCtD
Niacin—QPRT—Metabolism—GSTP1—urinary bladder cancer	0.000296	0.00105	CbGpPWpGaD
Niacin—Rhinitis—Epirubicin—urinary bladder cancer	0.000296	0.000779	CcSEcCtD
Niacin—Abdominal pain—Etoposide—urinary bladder cancer	0.000295	0.000779	CcSEcCtD
Niacin—Body temperature increased—Etoposide—urinary bladder cancer	0.000295	0.000779	CcSEcCtD
Niacin—Haemorrhage—Epirubicin—urinary bladder cancer	0.000295	0.000777	CcSEcCtD
Niacin—Hepatitis—Epirubicin—urinary bladder cancer	0.000295	0.000777	CcSEcCtD
Niacin—Eye disorder—Methotrexate—urinary bladder cancer	0.000294	0.000776	CcSEcCtD
Niacin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000294	0.000776	CcSEcCtD
Niacin—Tinnitus—Methotrexate—urinary bladder cancer	0.000294	0.000774	CcSEcCtD
Niacin—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000293	0.000773	CcSEcCtD
Niacin—Asthenia—Cisplatin—urinary bladder cancer	0.000293	0.000771	CcSEcCtD
Niacin—Sweating—Doxorubicin—urinary bladder cancer	0.000291	0.000768	CcSEcCtD
Niacin—Oedema peripheral—Epirubicin—urinary bladder cancer	0.00029	0.000765	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—RBX1—urinary bladder cancer	0.000289	0.00103	CbGpPWpGaD
Niacin—QPRT—Disease—MTHFR—urinary bladder cancer	0.000287	0.00102	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TSC1—urinary bladder cancer	0.000286	0.00102	CbGpPWpGaD
Niacin—QPRT—Disease—TERT—urinary bladder cancer	0.000286	0.00102	CbGpPWpGaD
Niacin—Angiopathy—Methotrexate—urinary bladder cancer	0.000286	0.000753	CcSEcCtD
Niacin—Dizziness—Fluorouracil—urinary bladder cancer	0.000284	0.00075	CcSEcCtD
Niacin—Visual impairment—Epirubicin—urinary bladder cancer	0.000284	0.000749	CcSEcCtD
Niacin—Chills—Methotrexate—urinary bladder cancer	0.000283	0.000745	CcSEcCtD
Niacin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000279	0.000736	CcSEcCtD
Niacin—Alopecia—Methotrexate—urinary bladder cancer	0.000278	0.000734	CcSEcCtD
Niacin—Vomiting—Gemcitabine—urinary bladder cancer	0.000278	0.000733	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—SRC—urinary bladder cancer	0.000276	0.000986	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—TYMP—urinary bladder cancer	0.000276	0.000985	CbGpPWpGaD
Niacin—Rash—Gemcitabine—urinary bladder cancer	0.000276	0.000727	CcSEcCtD
Niacin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000276	0.000727	CcSEcCtD
Niacin—Eye disorder—Epirubicin—urinary bladder cancer	0.000275	0.000726	CcSEcCtD
Niacin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000275	0.000726	CcSEcCtD
Niacin—NNMT—Metabolism—GSTP1—urinary bladder cancer	0.000275	0.00098	CbGpPWpGaD
Niacin—QPRT—Metabolism—TYMS—urinary bladder cancer	0.000275	0.00098	CbGpPWpGaD
Niacin—Tinnitus—Epirubicin—urinary bladder cancer	0.000275	0.000724	CcSEcCtD
Niacin—Erythema—Methotrexate—urinary bladder cancer	0.000274	0.000723	CcSEcCtD
Niacin—Malnutrition—Methotrexate—urinary bladder cancer	0.000274	0.000723	CcSEcCtD
Niacin—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000274	0.000723	CcSEcCtD
Niacin—Headache—Gemcitabine—urinary bladder cancer	0.000274	0.000723	CcSEcCtD
Niacin—Flushing—Epirubicin—urinary bladder cancer	0.000274	0.000721	CcSEcCtD
Niacin—Vomiting—Fluorouracil—urinary bladder cancer	0.000274	0.000721	CcSEcCtD
Niacin—Rhinitis—Doxorubicin—urinary bladder cancer	0.000273	0.000721	CcSEcCtD
Niacin—Hepatitis—Doxorubicin—urinary bladder cancer	0.000273	0.000719	CcSEcCtD
Niacin—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000273	0.000719	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—JAG1—urinary bladder cancer	0.000273	0.000973	CbGpPWpGaD
Niacin—QPRT—Metabolism—GSTM1—urinary bladder cancer	0.000272	0.000969	CbGpPWpGaD
Niacin—QPRT—Metabolism—NCOR1—urinary bladder cancer	0.000272	0.000969	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TSC1—urinary bladder cancer	0.000272	0.000969	CbGpPWpGaD
Niacin—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000271	0.000715	CcSEcCtD
Niacin—Rash—Fluorouracil—urinary bladder cancer	0.000271	0.000715	CcSEcCtD
Niacin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000271	0.000714	CcSEcCtD
Niacin—Headache—Fluorouracil—urinary bladder cancer	0.000269	0.00071	CcSEcCtD
Niacin—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000269	0.000708	CcSEcCtD
Niacin—Asthenia—Etoposide—urinary bladder cancer	0.000268	0.000707	CcSEcCtD
Niacin—Angiopathy—Epirubicin—urinary bladder cancer	0.000267	0.000705	CcSEcCtD
Niacin—SLC22A5—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000266	0.00095	CbGpPWpGaD
Niacin—Chills—Epirubicin—urinary bladder cancer	0.000264	0.000697	CcSEcCtD
Niacin—Pruritus—Etoposide—urinary bladder cancer	0.000264	0.000697	CcSEcCtD
Niacin—Arrhythmia—Epirubicin—urinary bladder cancer	0.000263	0.000694	CcSEcCtD
Niacin—Visual impairment—Doxorubicin—urinary bladder cancer	0.000263	0.000693	CcSEcCtD
Niacin—QPRT—Disease—FGFR3—urinary bladder cancer	0.000262	0.000936	CbGpPWpGaD
Niacin—Alopecia—Epirubicin—urinary bladder cancer	0.00026	0.000687	CcSEcCtD
Niacin—QPRT—Metabolism—GPX1—urinary bladder cancer	0.00026	0.000928	CbGpPWpGaD
Niacin—Nausea—Gemcitabine—urinary bladder cancer	0.00026	0.000685	CcSEcCtD
Niacin—SLC16A1—Metabolism—GSTZ1—urinary bladder cancer	0.00026	0.000926	CbGpPWpGaD
Niacin—Vomiting—Cisplatin—urinary bladder cancer	0.000259	0.000683	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—JAG1—urinary bladder cancer	0.000259	0.000922	CbGpPWpGaD
Niacin—Vision blurred—Methotrexate—urinary bladder cancer	0.000258	0.000681	CcSEcCtD
Niacin—Rash—Cisplatin—urinary bladder cancer	0.000257	0.000678	CcSEcCtD
Niacin—Dermatitis—Cisplatin—urinary bladder cancer	0.000257	0.000677	CcSEcCtD
Niacin—Erythema—Epirubicin—urinary bladder cancer	0.000257	0.000676	CcSEcCtD
Niacin—Malnutrition—Epirubicin—urinary bladder cancer	0.000257	0.000676	CcSEcCtD
Niacin—Diarrhoea—Etoposide—urinary bladder cancer	0.000256	0.000674	CcSEcCtD
Niacin—NNMT—Metabolism—TYMS—urinary bladder cancer	0.000256	0.000912	CbGpPWpGaD
Niacin—Nausea—Fluorouracil—urinary bladder cancer	0.000256	0.000674	CcSEcCtD
Niacin—QPRT—Metabolism—ERCC2—urinary bladder cancer	0.000255	0.000911	CbGpPWpGaD
Niacin—Eye disorder—Doxorubicin—urinary bladder cancer	0.000255	0.000672	CcSEcCtD
Niacin—Tinnitus—Doxorubicin—urinary bladder cancer	0.000254	0.00067	CcSEcCtD
Niacin—SLC16A3—Hemostasis—PLAU—urinary bladder cancer	0.000254	0.000906	CbGpPWpGaD
Niacin—Flushing—Doxorubicin—urinary bladder cancer	0.000253	0.000667	CcSEcCtD
Niacin—Flatulence—Epirubicin—urinary bladder cancer	0.000253	0.000667	CcSEcCtD
Niacin—NNMT—Metabolism—NCOR1—urinary bladder cancer	0.000253	0.000901	CbGpPWpGaD
Niacin—NNMT—Metabolism—GSTM1—urinary bladder cancer	0.000253	0.000901	CbGpPWpGaD
Niacin—Tension—Epirubicin—urinary bladder cancer	0.000252	0.000664	CcSEcCtD
Niacin—SLC16A3—Metabolism—NAT2—urinary bladder cancer	0.00025	0.000891	CbGpPWpGaD
Niacin—Nervousness—Epirubicin—urinary bladder cancer	0.000249	0.000657	CcSEcCtD
Niacin—Angiopathy—Doxorubicin—urinary bladder cancer	0.000247	0.000652	CcSEcCtD
Niacin—Dizziness—Etoposide—urinary bladder cancer	0.000247	0.000651	CcSEcCtD
Niacin—Muscle spasms—Epirubicin—urinary bladder cancer	0.000247	0.00065	CcSEcCtD
Niacin—Vertigo—Methotrexate—urinary bladder cancer	0.000246	0.000649	CcSEcCtD
Niacin—SLC16A1—Metabolism—NAT1—urinary bladder cancer	0.000246	0.000878	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTO2—urinary bladder cancer	0.000246	0.000878	CbGpPWpGaD
Niacin—Leukopenia—Methotrexate—urinary bladder cancer	0.000245	0.000647	CcSEcCtD
Niacin—Chills—Doxorubicin—urinary bladder cancer	0.000245	0.000645	CcSEcCtD
Niacin—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000244	0.000642	CcSEcCtD
Niacin—Nausea—Cisplatin—urinary bladder cancer	0.000242	0.000639	CcSEcCtD
Niacin—NNMT—Metabolism—GPX1—urinary bladder cancer	0.000242	0.000863	CbGpPWpGaD
Niacin—Vision blurred—Epirubicin—urinary bladder cancer	0.000242	0.000637	CcSEcCtD
Niacin—Alopecia—Doxorubicin—urinary bladder cancer	0.000241	0.000635	CcSEcCtD
Niacin—QPRT—Metabolism—MTHFR—urinary bladder cancer	0.00024	0.000857	CbGpPWpGaD
Niacin—Cough—Methotrexate—urinary bladder cancer	0.000239	0.000631	CcSEcCtD
Niacin—Vomiting—Etoposide—urinary bladder cancer	0.000238	0.000626	CcSEcCtD
Niacin—NNMT—Metabolism—ERCC2—urinary bladder cancer	0.000237	0.000847	CbGpPWpGaD
Niacin—Erythema—Doxorubicin—urinary bladder cancer	0.000237	0.000626	CcSEcCtD
Niacin—Malnutrition—Doxorubicin—urinary bladder cancer	0.000237	0.000626	CcSEcCtD
Niacin—Rash—Etoposide—urinary bladder cancer	0.000236	0.000621	CcSEcCtD
Niacin—SLCO2B1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000235	0.00084	CbGpPWpGaD
Niacin—Dermatitis—Etoposide—urinary bladder cancer	0.000235	0.00062	CcSEcCtD
Niacin—Headache—Etoposide—urinary bladder cancer	0.000234	0.000617	CcSEcCtD
Niacin—Flatulence—Doxorubicin—urinary bladder cancer	0.000234	0.000617	CcSEcCtD
Niacin—Myalgia—Methotrexate—urinary bladder cancer	0.000233	0.000615	CcSEcCtD
Niacin—Arthralgia—Methotrexate—urinary bladder cancer	0.000233	0.000615	CcSEcCtD
Niacin—Tension—Doxorubicin—urinary bladder cancer	0.000233	0.000614	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000232	0.000611	CcSEcCtD
Niacin—Nervousness—Doxorubicin—urinary bladder cancer	0.000231	0.000608	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—RHOA—urinary bladder cancer	0.000231	0.000822	CbGpPWpGaD
Niacin—Vertigo—Epirubicin—urinary bladder cancer	0.000231	0.000608	CcSEcCtD
Niacin—Syncope—Epirubicin—urinary bladder cancer	0.00023	0.000607	CcSEcCtD
Niacin—Leukopenia—Epirubicin—urinary bladder cancer	0.00023	0.000605	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—KRAS—urinary bladder cancer	0.000229	0.000816	CbGpPWpGaD
Niacin—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000228	0.000602	CcSEcCtD
Niacin—Palpitations—Epirubicin—urinary bladder cancer	0.000227	0.000598	CcSEcCtD
Niacin—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000226	0.000595	CcSEcCtD
Niacin—SLC16A1—Metabolism—UGT2B7—urinary bladder cancer	0.000225	0.000803	CbGpPWpGaD
Niacin—Cough—Epirubicin—urinary bladder cancer	0.000224	0.00059	CcSEcCtD
Niacin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000224	0.00059	CcSEcCtD
Niacin—Vision blurred—Doxorubicin—urinary bladder cancer	0.000224	0.00059	CcSEcCtD
Niacin—QPRT—Disease—CREBBP—urinary bladder cancer	0.000223	0.000797	CbGpPWpGaD
Niacin—NNMT—Metabolism—MTHFR—urinary bladder cancer	0.000223	0.000796	CbGpPWpGaD
Niacin—Nausea—Etoposide—urinary bladder cancer	0.000222	0.000585	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—S100B—urinary bladder cancer	0.000221	0.000788	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—NAT2—urinary bladder cancer	0.00022	0.000784	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—RHOA—urinary bladder cancer	0.000219	0.00078	CbGpPWpGaD
Niacin—Myalgia—Epirubicin—urinary bladder cancer	0.000218	0.000576	CcSEcCtD
Niacin—Arthralgia—Epirubicin—urinary bladder cancer	0.000218	0.000576	CcSEcCtD
Niacin—Skin disorder—Methotrexate—urinary bladder cancer	0.000217	0.000573	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000217	0.000572	CcSEcCtD
Niacin—CYP2D6—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000217	0.000773	CbGpPWpGaD
Niacin—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000216	0.00057	CcSEcCtD
Niacin—SLC16A3—Metabolism—RRM2—urinary bladder cancer	0.000216	0.000769	CbGpPWpGaD
Niacin—Dry mouth—Epirubicin—urinary bladder cancer	0.000214	0.000563	CcSEcCtD
Niacin—Vertigo—Doxorubicin—urinary bladder cancer	0.000213	0.000562	CcSEcCtD
Niacin—Anorexia—Methotrexate—urinary bladder cancer	0.000213	0.000562	CcSEcCtD
Niacin—Syncope—Doxorubicin—urinary bladder cancer	0.000213	0.000561	CcSEcCtD
Niacin—Leukopenia—Doxorubicin—urinary bladder cancer	0.000213	0.00056	CcSEcCtD
Niacin—Palpitations—Doxorubicin—urinary bladder cancer	0.00021	0.000553	CcSEcCtD
Niacin—SLC16A3—Hemostasis—CREBBP—urinary bladder cancer	0.000209	0.000747	CbGpPWpGaD
Niacin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000209	0.000552	CcSEcCtD
Niacin—Oedema—Epirubicin—urinary bladder cancer	0.000209	0.000552	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—RHOA—urinary bladder cancer	0.000209	0.000747	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—S100B—urinary bladder cancer	0.000209	0.000747	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000209	0.000746	CbGpPWpGaD
Niacin—Hypotension—Methotrexate—urinary bladder cancer	0.000209	0.000551	CcSEcCtD
Niacin—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000209	0.00055	CcSEcCtD
Niacin—Cough—Doxorubicin—urinary bladder cancer	0.000207	0.000546	CcSEcCtD
Niacin—SLC16A3—Hemostasis—IGF1—urinary bladder cancer	0.000207	0.000738	CbGpPWpGaD
Niacin—Shock—Epirubicin—urinary bladder cancer	0.000206	0.000543	CcSEcCtD
Niacin—Tachycardia—Epirubicin—urinary bladder cancer	0.000204	0.000539	CcSEcCtD
Niacin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000204	0.000537	CcSEcCtD
Niacin—Skin disorder—Epirubicin—urinary bladder cancer	0.000203	0.000536	CcSEcCtD
Niacin—SLC16A1—Metabolism—CYP4B1—urinary bladder cancer	0.000203	0.000723	CbGpPWpGaD
Niacin—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000202	0.000534	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—CXCL8—urinary bladder cancer	0.000202	0.000722	CbGpPWpGaD
Niacin—Insomnia—Methotrexate—urinary bladder cancer	0.000202	0.000534	CcSEcCtD
Niacin—Myalgia—Doxorubicin—urinary bladder cancer	0.000202	0.000533	CcSEcCtD
Niacin—Arthralgia—Doxorubicin—urinary bladder cancer	0.000202	0.000533	CcSEcCtD
Niacin—QPRT—Disease—RHOA—urinary bladder cancer	0.000202	0.000721	CbGpPWpGaD
Niacin—Paraesthesia—Methotrexate—urinary bladder cancer	0.000201	0.00053	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000201	0.000529	CcSEcCtD
Niacin—SLC16A3—Metabolism—HPGDS—urinary bladder cancer	0.0002	0.000712	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ENO2—urinary bladder cancer	0.0002	0.000712	CbGpPWpGaD
Niacin—Anorexia—Epirubicin—urinary bladder cancer	0.0002	0.000526	CcSEcCtD
Niacin—Dyspnoea—Methotrexate—urinary bladder cancer	0.0002	0.000526	CcSEcCtD
Niacin—Somnolence—Methotrexate—urinary bladder cancer	0.000199	0.000524	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—NCOR1—urinary bladder cancer	0.000199	0.000708	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—RHOA—urinary bladder cancer	0.000198	0.000708	CbGpPWpGaD
Niacin—Dry mouth—Doxorubicin—urinary bladder cancer	0.000198	0.000521	CcSEcCtD
Niacin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000197	0.000519	CcSEcCtD
Niacin—Hypotension—Epirubicin—urinary bladder cancer	0.000196	0.000516	CcSEcCtD
Niacin—QPRT—Metabolism—PPARG—urinary bladder cancer	0.000195	0.000695	CbGpPWpGaD
Niacin—Decreased appetite—Methotrexate—urinary bladder cancer	0.000195	0.000513	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—HRAS—urinary bladder cancer	0.000194	0.000694	CbGpPWpGaD
Niacin—Oedema—Doxorubicin—urinary bladder cancer	0.000194	0.000511	CcSEcCtD
Niacin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000194	0.000511	CcSEcCtD
Niacin—SLC16A3—Metabolism—GSTT1—urinary bladder cancer	0.000194	0.000691	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—IL2—urinary bladder cancer	0.000193	0.00069	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IFNA2—urinary bladder cancer	0.000193	0.000689	CbGpPWpGaD
Niacin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000193	0.000509	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—CXCL8—urinary bladder cancer	0.000192	0.000684	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC19A1—urinary bladder cancer	0.000191	0.000683	CbGpPWpGaD
Niacin—Pain—Methotrexate—urinary bladder cancer	0.000191	0.000504	CcSEcCtD
Niacin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000191	0.000503	CcSEcCtD
Niacin—Shock—Doxorubicin—urinary bladder cancer	0.000191	0.000503	CcSEcCtD
Niacin—SLC16A3—Hemostasis—RHOA—urinary bladder cancer	0.000189	0.000676	CbGpPWpGaD
Niacin—Insomnia—Epirubicin—urinary bladder cancer	0.000189	0.000499	CcSEcCtD
Niacin—Tachycardia—Doxorubicin—urinary bladder cancer	0.000189	0.000499	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—NCOR1—urinary bladder cancer	0.000188	0.000672	CbGpPWpGaD
Niacin—Skin disorder—Doxorubicin—urinary bladder cancer	0.000188	0.000496	CcSEcCtD
Niacin—Paraesthesia—Epirubicin—urinary bladder cancer	0.000188	0.000496	CcSEcCtD
Niacin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000187	0.000494	CcSEcCtD
Niacin—QPRT—Metabolism—CREBBP—urinary bladder cancer	0.000187	0.000667	CbGpPWpGaD
Niacin—QPRT—Disease—ERBB2—urinary bladder cancer	0.000187	0.000667	CbGpPWpGaD
Niacin—Dyspnoea—Epirubicin—urinary bladder cancer	0.000187	0.000492	CcSEcCtD
Niacin—SLC16A1—Metabolism—PRSS3—urinary bladder cancer	0.000187	0.000665	CbGpPWpGaD
Niacin—Somnolence—Epirubicin—urinary bladder cancer	0.000186	0.000491	CcSEcCtD
Niacin—Anorexia—Doxorubicin—urinary bladder cancer	0.000185	0.000487	CcSEcCtD
Niacin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000184	0.000486	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—CXCL8—urinary bladder cancer	0.000184	0.000656	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—IL2—urinary bladder cancer	0.000183	0.000654	CbGpPWpGaD
Niacin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000183	0.000482	CcSEcCtD
Niacin—QPRT—Disease—PTGS2—urinary bladder cancer	0.000183	0.000652	CbGpPWpGaD
Niacin—Decreased appetite—Epirubicin—urinary bladder cancer	0.000182	0.00048	CcSEcCtD
Niacin—SLC16A3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000181	0.000647	CbGpPWpGaD
Niacin—Hypotension—Doxorubicin—urinary bladder cancer	0.000181	0.000477	CcSEcCtD
Niacin—NNMT—Metabolism—PPARG—urinary bladder cancer	0.000181	0.000646	CbGpPWpGaD
Niacin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000181	0.000477	CcSEcCtD
Niacin—SLC22A5—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.00018	0.000642	CbGpPWpGaD
Niacin—Pain—Epirubicin—urinary bladder cancer	0.000179	0.000472	CcSEcCtD
Niacin—Urticaria—Methotrexate—urinary bladder cancer	0.000178	0.000469	CcSEcCtD
Niacin—Body temperature increased—Methotrexate—urinary bladder cancer	0.000177	0.000466	CcSEcCtD
Niacin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000177	0.000466	CcSEcCtD
Niacin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000177	0.000465	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—IL2—urinary bladder cancer	0.000176	0.000627	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—HPGDS—urinary bladder cancer	0.000176	0.000626	CbGpPWpGaD
Niacin—Insomnia—Doxorubicin—urinary bladder cancer	0.000175	0.000462	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—TERT—urinary bladder cancer	0.000175	0.000624	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—CXCL8—urinary bladder cancer	0.000174	0.000622	CbGpPWpGaD
Niacin—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000174	0.000459	CcSEcCtD
Niacin—NNMT—Metabolism—CREBBP—urinary bladder cancer	0.000174	0.00062	CbGpPWpGaD
Niacin—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000173	0.000455	CcSEcCtD
Niacin—Somnolence—Doxorubicin—urinary bladder cancer	0.000172	0.000454	CcSEcCtD
Niacin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000171	0.000451	CcSEcCtD
Niacin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000171	0.00045	CcSEcCtD
Niacin—CYP2D6—Biological oxidations—GSTT1—urinary bladder cancer	0.00017	0.000608	CbGpPWpGaD
Niacin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000168	0.000444	CcSEcCtD
Niacin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000167	0.000441	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—IL2—urinary bladder cancer	0.000167	0.000594	CbGpPWpGaD
Niacin—Urticaria—Epirubicin—urinary bladder cancer	0.000166	0.000439	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—TERT—urinary bladder cancer	0.000166	0.000592	CbGpPWpGaD
Niacin—Pain—Doxorubicin—urinary bladder cancer	0.000166	0.000437	CcSEcCtD
Niacin—Body temperature increased—Epirubicin—urinary bladder cancer	0.000166	0.000436	CcSEcCtD
Niacin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000166	0.000436	CcSEcCtD
Niacin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000165	0.000435	CcSEcCtD
Niacin—SLC16A3—Metabolism—NQO1—urinary bladder cancer	0.000161	0.000574	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—FGFR3—urinary bladder cancer	0.000161	0.000573	CbGpPWpGaD
Niacin—Asthenia—Methotrexate—urinary bladder cancer	0.000161	0.000423	CcSEcCtD
Niacin—QPRT—Disease—CDKN1A—urinary bladder cancer	0.00016	0.00057	CbGpPWpGaD
Niacin—QPRT—Disease—PTEN—urinary bladder cancer	0.00016	0.000569	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—IL2—urinary bladder cancer	0.000159	0.000567	CbGpPWpGaD
Niacin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000158	0.000418	CcSEcCtD
Niacin—Pruritus—Methotrexate—urinary bladder cancer	0.000158	0.000417	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—ESR1—urinary bladder cancer	0.000156	0.000556	CbGpPWpGaD
Niacin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000154	0.000407	CcSEcCtD
Niacin—Urticaria—Doxorubicin—urinary bladder cancer	0.000154	0.000406	CcSEcCtD
Niacin—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000153	0.000404	CcSEcCtD
Niacin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000153	0.000404	CcSEcCtD
Niacin—QPRT—Metabolism—PTGS2—urinary bladder cancer	0.000153	0.000546	CbGpPWpGaD
Niacin—Diarrhoea—Methotrexate—urinary bladder cancer	0.000153	0.000404	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—FGFR3—urinary bladder cancer	0.000152	0.000543	CbGpPWpGaD
Niacin—QPRT—Disease—EP300—urinary bladder cancer	0.000152	0.000543	CbGpPWpGaD
Niacin—Asthenia—Epirubicin—urinary bladder cancer	0.00015	0.000396	CcSEcCtD
Niacin—SLC16A1—Metabolism—TYMP—urinary bladder cancer	0.000149	0.000532	CbGpPWpGaD
Niacin—Pruritus—Epirubicin—urinary bladder cancer	0.000148	0.000391	CcSEcCtD
Niacin—Dizziness—Methotrexate—urinary bladder cancer	0.000148	0.00039	CcSEcCtD
Niacin—QPRT—Disease—SRC—urinary bladder cancer	0.000148	0.000528	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ESR1—urinary bladder cancer	0.000148	0.000527	CbGpPWpGaD
Niacin—Diarrhoea—Epirubicin—urinary bladder cancer	0.000143	0.000378	CcSEcCtD
Niacin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000143	0.000376	CcSEcCtD
Niacin—SLC16A3—Hemostasis—EP300—urinary bladder cancer	0.000143	0.000509	CbGpPWpGaD
Niacin—NNMT—Metabolism—PTGS2—urinary bladder cancer	0.000142	0.000508	CbGpPWpGaD
Niacin—Vomiting—Methotrexate—urinary bladder cancer	0.000142	0.000375	CcSEcCtD
Niacin—Rash—Methotrexate—urinary bladder cancer	0.000141	0.000372	CcSEcCtD
Niacin—Dermatitis—Methotrexate—urinary bladder cancer	0.000141	0.000372	CcSEcCtD
Niacin—Headache—Methotrexate—urinary bladder cancer	0.00014	0.00037	CcSEcCtD
Niacin—Asthenia—Doxorubicin—urinary bladder cancer	0.000139	0.000366	CcSEcCtD
Niacin—SLC16A3—Hemostasis—SRC—urinary bladder cancer	0.000139	0.000495	CbGpPWpGaD
Niacin—Dizziness—Epirubicin—urinary bladder cancer	0.000138	0.000365	CcSEcCtD
Niacin—SLC16A1—Hemostasis—PLAU—urinary bladder cancer	0.000137	0.000489	CbGpPWpGaD
Niacin—Pruritus—Doxorubicin—urinary bladder cancer	0.000137	0.000361	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—CREBBP—urinary bladder cancer	0.000137	0.000488	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IGF1—urinary bladder cancer	0.000135	0.000482	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NAT2—urinary bladder cancer	0.000135	0.000481	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—EGFR—urinary bladder cancer	0.000134	0.000479	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GSTP1—urinary bladder cancer	0.000134	0.000479	CbGpPWpGaD
Niacin—QPRT—Metabolism—PTEN—urinary bladder cancer	0.000134	0.000477	CbGpPWpGaD
Niacin—Vomiting—Epirubicin—urinary bladder cancer	0.000133	0.000351	CcSEcCtD
Niacin—Nausea—Methotrexate—urinary bladder cancer	0.000133	0.00035	CcSEcCtD
Niacin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000133	0.000349	CcSEcCtD
Niacin—QPRT—Disease—MYC—urinary bladder cancer	0.000133	0.000473	CbGpPWpGaD
Niacin—Rash—Epirubicin—urinary bladder cancer	0.000132	0.000348	CcSEcCtD
Niacin—Dermatitis—Epirubicin—urinary bladder cancer	0.000132	0.000348	CcSEcCtD
Niacin—Headache—Epirubicin—urinary bladder cancer	0.000131	0.000346	CcSEcCtD
Niacin—QPRT—Disease—EGFR—urinary bladder cancer	0.00013	0.000462	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CREBBP—urinary bladder cancer	0.00013	0.000462	CbGpPWpGaD
Niacin—Dizziness—Doxorubicin—urinary bladder cancer	0.000128	0.000338	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—IGF1—urinary bladder cancer	0.000128	0.000457	CbGpPWpGaD
Niacin—QPRT—Metabolism—EP300—urinary bladder cancer	0.000127	0.000454	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—EGFR—urinary bladder cancer	0.000127	0.000454	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—KRAS—urinary bladder cancer	0.000127	0.000453	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—TYMS—urinary bladder cancer	0.000125	0.000445	CbGpPWpGaD
Niacin—Nausea—Epirubicin—urinary bladder cancer	0.000124	0.000328	CcSEcCtD
Niacin—NNMT—Metabolism—PTEN—urinary bladder cancer	0.000124	0.000443	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—RHOA—urinary bladder cancer	0.000124	0.000441	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GSTM1—urinary bladder cancer	0.000123	0.00044	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—NCOR1—urinary bladder cancer	0.000123	0.00044	CbGpPWpGaD
Niacin—Vomiting—Doxorubicin—urinary bladder cancer	0.000123	0.000325	CcSEcCtD
Niacin—QPRT—Disease—KRAS—urinary bladder cancer	0.000122	0.000437	CbGpPWpGaD
Niacin—Rash—Doxorubicin—urinary bladder cancer	0.000122	0.000322	CcSEcCtD
Niacin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000122	0.000322	CcSEcCtD
Niacin—Headache—Doxorubicin—urinary bladder cancer	0.000121	0.00032	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—KRAS—urinary bladder cancer	0.00012	0.000429	CbGpPWpGaD
Niacin—NNMT—Metabolism—EP300—urinary bladder cancer	0.000118	0.000422	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GPX1—urinary bladder cancer	0.000118	0.000421	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	0.000118	0.000421	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—RHOA—urinary bladder cancer	0.000117	0.000418	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000116	0.000415	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—RRM2—urinary bladder cancer	0.000116	0.000415	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ERCC2—urinary bladder cancer	0.000116	0.000414	CbGpPWpGaD
Niacin—Nausea—Doxorubicin—urinary bladder cancer	0.000115	0.000303	CcSEcCtD
Niacin—SLC16A3—Hemostasis—KRAS—urinary bladder cancer	0.000115	0.00041	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—ERBB2—urinary bladder cancer	0.000114	0.000408	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—CREBBP—urinary bladder cancer	0.000113	0.000403	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IGF1—urinary bladder cancer	0.000112	0.000398	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.00011	0.000393	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—MTHFR—urinary bladder cancer	0.000109	0.000389	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CXCL8—urinary bladder cancer	0.000109	0.000387	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ERBB2—urinary bladder cancer	0.000109	0.000387	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	0.000109	0.000387	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—HRAS—urinary bladder cancer	0.000108	0.000385	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ENO2—urinary bladder cancer	0.000108	0.000385	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—HPGDS—urinary bladder cancer	0.000108	0.000385	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000107	0.000382	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTT1—urinary bladder cancer	0.000105	0.000373	CbGpPWpGaD
Niacin—QPRT—Disease—HRAS—urinary bladder cancer	0.000104	0.000371	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL2—urinary bladder cancer	0.000104	0.00037	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CXCL8—urinary bladder cancer	0.000103	0.000367	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—RHOA—urinary bladder cancer	0.000102	0.000365	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—HRAS—urinary bladder cancer	0.000102	0.000365	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TP53—urinary bladder cancer	0.000102	0.000364	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CCND1—urinary bladder cancer	0.000101	0.000361	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL2—urinary bladder cancer	9.84e-05	0.000351	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MMP9—urinary bladder cancer	9.82e-05	0.00035	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	9.79e-05	0.000349	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CDKN1A—urinary bladder cancer	9.79e-05	0.000349	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—HRAS—urinary bladder cancer	9.76e-05	0.000348	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PTEN—urinary bladder cancer	9.76e-05	0.000348	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCND1—urinary bladder cancer	9.59e-05	0.000342	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EP300—urinary bladder cancer	9.31e-05	0.000332	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MMP9—urinary bladder cancer	9.31e-05	0.000332	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CDKN1A—urinary bladder cancer	9.28e-05	0.000331	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PTEN—urinary bladder cancer	9.26e-05	0.00033	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SRC—urinary bladder cancer	9.05e-05	0.000323	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PPARG—urinary bladder cancer	8.84e-05	0.000315	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EP300—urinary bladder cancer	8.83e-05	0.000315	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NQO1—urinary bladder cancer	8.69e-05	0.00031	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IL2—urinary bladder cancer	8.59e-05	0.000306	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SRC—urinary bladder cancer	8.58e-05	0.000306	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CREBBP—urinary bladder cancer	8.49e-05	0.000303	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8.42e-05	0.0003	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MYC—urinary bladder cancer	8.11e-05	0.000289	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EGFR—urinary bladder cancer	7.94e-05	0.000283	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—EP300—urinary bladder cancer	7.7e-05	0.000275	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MYC—urinary bladder cancer	7.69e-05	0.000274	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EGFR—urinary bladder cancer	7.52e-05	0.000268	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—KRAS—urinary bladder cancer	7.5e-05	0.000267	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—SRC—urinary bladder cancer	7.49e-05	0.000267	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTP1—urinary bladder cancer	7.25e-05	0.000259	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	7.23e-05	0.000258	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—KRAS—urinary bladder cancer	7.11e-05	0.000254	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTGS2—urinary bladder cancer	6.95e-05	0.000248	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NAT1—urinary bladder cancer	6.86e-05	0.000245	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	6.86e-05	0.000245	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—TYMS—urinary bladder cancer	6.74e-05	0.00024	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TP53—urinary bladder cancer	6.66e-05	0.000238	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NCOR1—urinary bladder cancer	6.66e-05	0.000238	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTM1—urinary bladder cancer	6.66e-05	0.000238	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GPX1—urinary bladder cancer	6.38e-05	0.000228	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HRAS—urinary bladder cancer	6.37e-05	0.000227	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TP53—urinary bladder cancer	6.32e-05	0.000225	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	6.27e-05	0.000224	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ERCC2—urinary bladder cancer	6.26e-05	0.000223	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—KRAS—urinary bladder cancer	6.2e-05	0.000221	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTEN—urinary bladder cancer	6.06e-05	0.000216	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HRAS—urinary bladder cancer	6.04e-05	0.000215	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—MTHFR—urinary bladder cancer	5.89e-05	0.00021	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—EP300—urinary bladder cancer	5.78e-05	0.000206	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	5.65e-05	0.000201	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TP53—urinary bladder cancer	5.51e-05	0.000197	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	5.33e-05	0.00019	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—HRAS—urinary bladder cancer	5.27e-05	0.000188	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	5.2e-05	0.000185	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PPARG—urinary bladder cancer	4.77e-05	0.00017	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CREBBP—urinary bladder cancer	4.59e-05	0.000164	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TYMP—urinary bladder cancer	4.15e-05	0.000148	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NAT2—urinary bladder cancer	3.76e-05	0.000134	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTGS2—urinary bladder cancer	3.76e-05	0.000134	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTEN—urinary bladder cancer	3.28e-05	0.000117	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—RRM2—urinary bladder cancer	3.24e-05	0.000116	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—EP300—urinary bladder cancer	3.12e-05	0.000111	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	3e-05	0.000107	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ENO2—urinary bladder cancer	3e-05	0.000107	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	2.91e-05	0.000104	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NQO1—urinary bladder cancer	2.42e-05	8.64e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	2.02e-05	7.2e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.88e-05	6.7e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.86e-05	6.62e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.86e-05	6.62e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.78e-05	6.34e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.74e-05	6.22e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.64e-05	5.85e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.33e-05	4.74e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.28e-05	4.56e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.05e-05	3.73e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTEN—urinary bladder cancer	9.12e-06	3.25e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—EP300—urinary bladder cancer	8.7e-06	3.1e-05	CbGpPWpGaD
